CLINICAL_TRIALS
trial_result
· 2010-11-18
Clinical Trial Update: Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes [Phase 4]
Summary
Phase 4 trial update on pioglitazone and serum asymmetric dimethylarginine (ADMA) in patients with diabetes; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2010-11-18